Estrogenic activity of stilbene derivatives

Journal of Health Science

Volumn 49, Issue 5, 2003, Pages 359-367

  Sanoh, Seigo ^a   Kitamura, Shigeyuki ^a   Sugihara, Kazumi ^a   Fujimoto, Nariaki ^b   Ohta, Shigeru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Estrogenic activity; Human breast cancer cell MCF 7; Stilbene derivative; Stilbene proestrogen; Structure activity relationship

Indexed keywords

3 METHYLCHOLANTHRENE; 4 AMINO 4' HYDROXYSTILBENE; 4 AMINOSTILBENE; 4 HYDROXY 4' NITROSTILBENE; 4 HYDROXYAZOBENZENE; 4 HYDROXYMETHYLSTILBENE; 4 HYDROXYSTILBENE; 4 ISOPROPENYLPHENOL; 4 NITROSTILBENE; 4,4' DIHYDROXY ALPHA METHYLSTILBENE; 4,4' DIHYDROXYSTILBENE; 4,4' DIMETHOXYSTILBENE; ALPHA METHYLSTILBENE; ALPHA METHYLSTYRENE; AZOBENZENE; BENZENE DERIVATIVE; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; HEXESTROL; HYDROXYL GROUP; NITRO DERIVATIVE; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; STILBENE DERIVATIVE; TOLAN; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; INCUBATION TIME; LIVER MICROSOME; MALE; NONHUMAN; RAT; UTERUS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 2942758141     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.49.359     Document Type: Article

References (30)

1. Grundy, J. (1957) Artifical estrogens. Chem. Rev., 57, 281-356.
2. Hughes, G. M. K., Moore, P. F. and Stebbins, R. B. (1964) Some hypocholesteremic 2,3-diphenyl-acrylonitriles. J. Med. Chem., 7, 511-518.
3. Ali, H. A., Kondo, K. and Tsuda, Y. (1992) Synthesis and nematocidal activity of hydroxystilbenes. Chem. Pharm. Bull., 40, 1130-1136.
4. Matsuda, H., Tomohiro, N., Hiraba, K., Harima, S., Ko, S., Matsuo, K., Yoshikawa, M. and Kubo, M. (2001) Study on anti-Oketsu activity of rhubarb II. Anti-allergic effects of stilbene compounds from Rhei undulati Rhizomma (dried rhizome of Rheum undulatum cultivated in Korea). Biol. Pharm. Bull., 24, 264-267.
5. Metzler, M. (1984) Biochemical toxicology of diethylstilbestrol. Rev. Biochem. Toxicol., 6, 191-220.
6. Smith, O. W. and Brookline, M. (1948) Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am. J. Obstet. Gynecol., 56, 821-825.
7. Herbst, A. L., Ulfelder, H. and Poskanzer, D. C. (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med., 284, 878-881.
8. Melchior, F. and Kindl, H. (1991) Coordinate- and elicitor-dependent expression of stilbene synthase and phenylalanine ammonia-lyase genes in Vitis cv. Optima. Arch. Biochem. Biophys., 288, 552-557.
9. Schröder, G., Brown, J. W. S. and Schröder, J. (1988) Molecular analysis of resveratrol synthase. CDNA, genomic clones and relationship with chalcone synthase. Eur. J. Biochem., 172, 101-109.
10. Constant, J. (1997) Alcohol, ischemic heart disease, and the French paradox. Coron. Artery Dis., 8, 645-649.
11. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
12. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E. and Savouret, J.-F. (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol. Pharmacol., 56, 784-790.
13. Gehm, B. D., McAndrews, J. M., Chien, P.-Y. and Jameson, J. L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A., 94, 14138-14143.
14. Lu, R. and Serrero, G. (1999) Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell. Physiol., 179, 297-304.
15. Colborn, T. (1995) Environmental estrogens: Health implications for humans and wildlife. Environ. Health Perspect., 103, 135-136.
16. Andersen, H. R., Andersson, A.-M., Arnold, S. F., Autrup, H., Barfoed, M., Beresford, N. A., Bjerregaard, P., Christiansen, L. B., Gissel, B. and Hummel, R., et al. (1999) Comparison of short-term estrogenicity test for identification of hormone-disrupting chemicals. Environ. Health Perspect., 107 (Suppl. 1), 89-108.
17. Katzenellenbogen, J. A. (1995) The structural pervasiveness of estrogenic activity. Environ. Health Perspect., 103 (Suppl. 7), 99-101.
18. Anstead, G. M., Carlson, K. E. and Katzenellenbogen, J. A. (1997) The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids, 62, 268-303.
19. Blair, R. M., Fang, H., Branham, W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R. and Sheehan, D. M. (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci., 54, 138-153.
20. Nishihara, T., Nishikawa, J., Kanayama, T., Dakeyama, F., Saito, K., Imagawa, M., Takatori, S., Kitagawa, Y., Hori, S. and Utsumi, H. (2000) Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J. Health Sci., 46, 282-298.
21. Fang, H., Tong, W., Perkins, R., Soto, A. M., Prechtl, N. V. and Sheehan, D. M. (2000) Quantitative comparisons of in vitro assay for estrogenic activities. Environ. Health Perspect., 1081, 723-729.
22. Fang, H., Tong, W., Shi, L. M., Blair, R., Perkins, R., Branham, W., Hass, B. S., Xie, Q., Dial, S. L., Moland, C. L. and Sheehan, D. M. (2001) Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol., 14, 280-294.
23. Shi, L. M., Fang, H., Tong, W., Wu, J., Perkins, R., Blair, R. M., Branham, W. S., Dial, S. L., Moland, C. L. and Sheehan, D. M. (2001) QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci., 41, 186-195.
24. Hong, H., Tong, W., Fang, H., Shi, L., Xie, Q., Wu, J., Perkins, R., Walker, J. D., Branham, W. and Sheehan, D. M. (2002) Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. Environ. Health Perspect., 110, 29-36.
25. Sugihara, K., Kitamura, S., Sanoh, S., Ohta, S., Fujimoto, N., Maruyama, S. and Ito, A. (2000) Metabolic activation of the proestrogens trans-stilbene and trans-stilbene oxide by rat liver microsomes. Toxicol. Appl. Pharmacol., 167, 46-54.
26. Sanoh, S., Kitamura, S., Sugihara, K. and Ohta, S. (2002) Cytochrome P450 1A1/2 mediated metabolism of trans-stilbene in rats and humans. Biol. Pharm. Bull., 25, 397-400.
27. Kitamura, S., Ohmegi, M., Sanoh, S., Sugihara, K., Yoshihara, S., Fujimoto, N. and Ohta, S. (2003) Estrogenic activity of styrene oligomers after metabolic activation by rat liver microsomes. Environ. Health Perspect., 111, 329-334.
28. Fujimoto, T., Kitamura, S., Sanoh, S., Sugihara, K., Yoshihara, S., Fujimoto, N. and Ohta, S. (2003) Estrogenic activity of an environmental pollutant, 2-nitrofluorene, after metabolic activation by rat liver microsomes. Biochem. Biophys. Res. Commun., 303, 419-426.
29. Dodds, E. C., Fitzgerald, M. E. H. and Lawson, W (1937) Estrogenic activity of some hydrocarbon derivatives of ethylene. Nature (London), 140, 772.
30. Stroud, S. W. (1939) Preliminary investigation of the metabolism of stilbene. Nature (London), 144, 245.